MoneyWorks4Me

Sequent Scientific informs about analysts meet

13 May 2024 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that the Company has, as a part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Thursday, May 16, 2024, to discuss its Q4 FY24 financial results. The Conference call details are enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1210.45
Cipla 1366.80
Lupin 2119.40
Zydus Lifesciences 1167.20
View more..